ZYME

26.6300.86%
CE

Carlos E. Campoy

Independent Director

Mr. Carlos E. Campoy M.B.A. C.M.A., served as Senior Vice President at CytomX Therapeutics, Inc. since March, 2020 until September 30, 2022 and served as Chief Financial Officer at CytomX Therapeutics, Inc. since March, 2020 until September 24, 2022. He serves as an Independent Director at Zymeworks Inc. since June 30, 2023. He was a Chief Financial Officer of Alder Biopharmaceuticals, Inc., since December 12, 2018, which was acquired in October 2019 by Lundbeck A/S. Mr. Campoy has financial leadership and expertise across global publicly-traded companies, including biopharmaceutical and healthcare sectors. Mr. Campoy served as Vice President of Finance, International at Allergan plc from July 2014 to November 2016 where he had financial responsibility of sales, driving significant growth across all product divisions which included Neurosciences and BOTOX’. In this role, he led the strategic, operational and financial decision-making for the region and successfully designed and implemented new financial processes and organizational structure. Prior to joining Allergan, Mr. Campoy had tenure at Eli Lilly and Company, from 1996 to 2014, where he held a number of senior financial leadership positions including Chief Financial Officer, Eli Lilly Japan K.K., with financial responsibility of sales. He also served as U.S. Senior Director of Finance and Chief Financial Officer for the U.S. Specialty sales and marketing team with responsibility for planning, forecasting and reporting, financial controls, managed care, pricing, contrActing, sales analytics and distribution. He served as Partner of Think Forwards, a financial consulting firm focused on providing innovative solutions and transformational initiatives to drive growth from September 2017 to December 2018. Mr. Campoy is a Certified Management Accountant (CMA). He received an MBA in Finance and Decision Information Systems from Indiana University and a BS in Management from Faculdade C.C. Administracao de Tupa, in S’o Paulo, Brazil. He previously served on the Board of TP Orthodontics from 2006 to 2010.

Positions